The prognostic significance of preexisting diabetes in patients with surgically treated renal cell carcinoma: the ongoing debate

Affiliations

Editorial

Ho Won Kang et al. Ann Transl Med. 2019 Dec.

. 2019 Dec;7(Suppl 8):S321.

doi: 10.21037/atm.2019.09.131.

¹ Department of Urology, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, South Korea.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis.
Nayan M, Jalali S, Kapoor A, Finelli A, So A, Rendon R, Breau RH, Lavallee LT, Tanguay S, Heng D, Kawakami J, Basappa NS, Bjarnason G, Pouliot F, Hamilton RJ. Nayan M, et al. Urol Oncol. 2019 Sep;37(9):576.e11-576.e16. doi: 10.1016/j.urolonc.2019.06.006. Epub 2019 Jul 5. Urol Oncol. 2019. PMID: 31285115

1. Verhoest G, Veillard D, Guille F, et al. Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma. Eur Urol 2007;51:1298-304; discussion 304-5. 10.1016/j.eururo.2006.11.056 - DOI - PubMed
1. de Martino M, Leitner CV, Seemann C, et al. Preoperative serum cholesterol is an independent prognostic factor for patients with renal cell carcinoma (RCC). BJU Int 2015;115:397-404. 10.1111/bju.12767 - DOI - PubMed
1. Choi Y, Park B, Jeong BC, et al. Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis. Int J Cancer 2013;132:625-34. 10.1002/ijc.27639 - DOI - PubMed
1. Bono P, Elfving H, Utriainen T, et al. Hypertension and clinical benefit of bevacizumab in the treatment of advanced renal cell carcinoma. Ann Oncol 2009;20:393-4. 10.1093/annonc/mdn729 - DOI - PubMed
1. Chen L, Li H, Gu L, et al. The Impact of Diabetes Mellitus on Renal Cell Carcinoma Prognosis: A Meta-Analysis of Cohort Studies. Medicine (Baltimore) 2015;94:e1055. 10.1097/MD.0000000000001055 - DOI - PMC - PubMed